Libyan Rebels tell to loyalist Gaddafi:
The rebels have claimed that they are closing in on Gaddafi. Rebels’ interior minister Ahmed al-Darrad sees the asylum granted to Gaddafi and his family by Libya as an ‘enemy act’. The rebels demanded that Gaddafi and his family, who were given shelter in Algeria should be returned to Libya.
Rebel leaders seen making attempt to restore order in Libya, According to a report by Sydney Morning Herald,
Reporters touring Tripoli still saw chaotic scenes, including desperate motorists stealing fuel from a petrol station. In the capital's Souk al Jumma neighbourhood, about 200 people pounded on the doors of a bank, demanding that it open.
Rebel fighters were converging on Gaddafi's hometown of Sirte, which is his main remaining bastion, some 400 kilometres east of Tripoli.
The rebels gave pro-Gaddafi forces there a deadline of Saturday - the day after the end of the Muslim holiday - to complete negotiations and surrender.
After that, the rebels will "act decisively and militarily," Mustafa Abdul-Jalil, the head of the rebels' National Transitional Council, said on Tuesday.
The rebels gave pro-Gaddafi forces there a deadline of Saturday - the day after the end of the Muslim holiday - to complete negotiations and surrender.
After that, the rebels will "act decisively and militarily," Mustafa Abdul-Jalil, the head of the rebels' National Transitional Council, said on Tuesday.
Libyan Rebels tell to loyalist Gaddafi:
ReplyDelete‘Surrender or face attack’
The ultimatum given by Libyan rebels to of deposed Libyan leader the loyalists Muammar Gaddafi, ‘Surrender or face attack’.
The rebels have claimed that they are closing in on Gaddafi. Rebels’ interior minister Ahmed al-Darrad sees the asylum granted to Gaddafi and his family by Libya as an ‘enemy act’. The rebels demanded that Gaddafi and his family, who were given shelter in Algeria should be returned to Libya.
Rebel leaders seen making attempt to restore order in Libya, According to a report by Sydney Morning Herald,
Reporters touring Tripoli still saw chaotic scenes, including desperate motorists stealing fuel from a petrol station. In the capital's Souk al Jumma neighbourhood, about 200 people pounded on the doors of a bank, demanding that it open.
Rebel fighters were converging on Gaddafi's hometown of Sirte, which is his main remaining bastion, some 400 kilometres east of Tripoli.
The rebels gave pro-Gaddafi forces there a deadline of Saturday - the day after the end of the Muslim holiday - to complete negotiations and surrender.
After that, the rebels will "act decisively and militarily," Mustafa Abdul-Jalil, the head of the rebels' National Transitional Council, said on Tuesday.
Allergan’s Botox Cleared by U.S.
Allergan’s Botox Cleared by U.S. FDA for Urinary Incontinence; Shares Gain
Allergan Inc. Won U.S. clearance to market the wrinkle smoother Botox as a treatment for urinary incontinence.
The Food and Drug Administration approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement.
The medicine is injected into the bladder to increase its capacity by relaxing muscles.
Botox, also used to reduce facial wrinkles and treat neurological disorders, is the Irvine, California-based company’s top product with $1.4 billion in revenue last year. Sales of the drug for incontinence in people with MS and spinal cord injuries may reach $40 million in 2017, Seamus Fernandez, a Boston-based analyst at Leerink Swann & Co., said today in a note to investors.
“This approval of Botox is an important milestone in Allergan’s commitment to develop and make available novel treatment options for urologists and their patients,” Scott Whitcup, Allergan’s chief scientific officer and executive vice president for research and development, said running in a statement.
May bode well for eventual FDA clearance of Botox for idiopathic overactive bladder, a more common condition that may boost the drug’s sales by $210 million in 2017, Fernandez said. He said he expects Allergan to seek FDA clearance for that use next year, he said.
Botox, a purified form of the poison botulinum that blocks connections to nerves, won FDA approval in October as a treatment for chronic migraine headaches.
To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net